Jeena Sikho Lifecare Ltd
Jeena Sikho Lifecare Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
Guidance rank: #6 of 31 in Leisure Services
See the sector's top 10 — free with your mobile number.
The short version
Current operational beds: 2,300; long-term goal to expand to 7,000-10,000 beds in 3-5 years. Jeena Sikho Lifecare Limited targets a 4x to 5x increase in PAT over the next 4 years.
From Jeena Sikho Lifecare Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Current operational beds: 2,300; long-term goal to expand to 7,000-10,000 beds in 3-5 years.
- Ability to increase 2,000 beds within 9-12 months as needed, pending customer demand growth.
- Revenue target: INR 3,000 crores in 3-5 years, with balanced services and product mix (~50% each).
- Strategy focuses on preventive healthcare awareness to shift Indian mindset from curative to preventive.
- Target to admit 140,000 patients annually to generate around INR 1,400-1,500 crores turnover (0.01% of population).
- Planned product launches for BP, sugar, kidney, liver, depression, pregnancy to boost sales further.
- Product sales grew by INR 3 crores last month; repeat business in hospital at 26%, product side 34%.
2 more points from Jeena Sikho Lifecare Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Jeena Sikho Lifecare Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Manish Grover emphasized a significant future investment focus on research, aiming to build a large research wing within the next 2 years. This is expected to attract global patients from the US, UK, Middle East, and Australia for treatment and prevention.
- Current capital expenditure includes new asset additions of INR32 crores and transfer of INR10 crores from Work In Progress (WIP), totaling INR42 crores.
- The company plans bed capacity expansions, with the ability to add 2,000 beds within 9 months to a year as demand grows.
- Special new projects launching soon include pregnancy preparation products and Ayurvedic approaches to preventive care.
2 more points from Jeena Sikho Lifecare Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Leisure Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Jeena Sikho Lifecare Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Manish Grover mentioned having ready infrastructure to increase 2,000 beds within 9 months to a year whenever demand arises.
- The team is currently focused on creating customer readiness through awareness campaigns (TV shows like "Laughter Chefs," "MasterChef," "Khatron Ke Khiladi") to shift public mindset from curative to preventive care.
- Advance bookings/payments from preventive customers were temporarily delayed due to geopolitical concerns (Iran-America war fears) but have recently started normalizing with higher footfall.
- As of May 31, there are advances of around INR 8 crores carried forward to June.
2 more points from Jeena Sikho Lifecare Ltd's call on order book
Create a free account to keep reading this call
Jeena Sikho Lifecare Ltd — Quarterly revenue & net profit
Q4 FY26 figures are not in this chart yet. Latest shown: Dec 2025 (Q3 FY26). The Q4 FY26 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q3 FY26): revenue ₹222 Cr, net profit ₹67 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Jeena Sikho's management said in earlier quarters
Others in Leisure Services this season
- Sinclairs Hotels (Q4 FY26)
Revenue from operations for FY 2025-26: ₹5,923.91 lakh, up from ₹5,342.37 lakh in FY 2024-25, indicating a year-on-year growth of approximately 10.9%. Key…
- TSC India (Q4 FY26)
Revenue for H1 FY26: ₹13.44 crore (Page 24) . Key investor presentation takeaways from TSC India's Q4 FY26 investor presentation — and how it ranks against sect
- ITC Hotels (Q4 FY26)
Q4 FY26 Consolidated Revenue from Operations: ₹1,254 crore, up 18% YoY (Page 2, 13, 39) . Key concall takeaways from ITC Hotels Ltd's Q4 FY26 earnings call…
- TajGVK Hotels (Q4 FY26)
64 Cr (Green Woods Palaces & Resorts Pvt Ltd JV), Rs. Key concall takeaways from TajGVK Hotels & Resorts Ltd's Q4 FY26 earnings call — and how it ranks against…
Potential multibaggers · Q2 FY27
Potential multibaggers in Leisure Services
on management's own guidance
- Jubilant Foodworks LtdGood growth2
- Landmark GlobalGood growth1
- Leela Palaces HotelsGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Jeena Sikho Lifecare Ltd and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Jeena Sikho Lifecare Ltd Q4 FY26 results?
Current operational beds: 2,300; long-term goal to expand to 7,000-10,000 beds in 3-5 years. Jeena Sikho Lifecare Limited targets a 4x to 5x increase in PAT over the next 4 years.
What is Jeena Sikho Lifecare Ltd share price analysis?
Jeena Sikho Lifecare Ltd currently shows a neutral. The stock trades at a P/E of 32.4 with a market cap of ₹7,200 Cr. Investors should review the full earnings analysis for detailed insights.
Is Jeena Sikho Lifecare Ltd planning capital expenditure?
Manish Grover emphasized a significant future investment focus on research, aiming to build a large research wing within the next 2 years.
Keep Jeena Sikho Lifecare Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.